These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18674882)

  • 1. A study of voice therapy dropout.
    Hapner E; Portone-Maira C; Johns MM
    J Voice; 2009 May; 23(3):337-40. PubMed ID: 18674882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in temporal variables between voice therapy completers and dropouts.
    Portone-Maira C; Wise JC; Johns MM; Hapner ER
    J Voice; 2011 Jan; 25(1):62-6. PubMed ID: 20236797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The applicability of the dysphonia severity index and the voice handicap index in evaluating effects of voice therapy and phonosurgery.
    Hakkesteegt MM; Brocaar MP; Wieringa MH
    J Voice; 2010 Mar; 24(2):199-205. PubMed ID: 19185461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of quality-of-life instruments in predicting voice therapy dropout.
    Kavookjian H; Holcomb A; Garnett JD; Kraft S
    Laryngoscope; 2018 Dec; 128(12):2832-2837. PubMed ID: 30194864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.
    Braden MN; Johns MM; Klein AM; Delgaudio JM; Gilman M; Hapner ER
    J Voice; 2010 Mar; 24(2):242-9. PubMed ID: 19481417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the Voice Handicap Index-10 (VHI-10) and Voice-Related Quality of Life (V-RQOL) in patients with dysphonia.
    Romak JJ; Orbelo DM; Maragos NE; Ekbom DC
    J Voice; 2014 Mar; 28(2):237-40. PubMed ID: 24321582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence.
    Ebersole B; Soni RS; Moran K; Lango M; Devarajan K; Jamal N
    J Voice; 2018 May; 32(3):325-331. PubMed ID: 28709763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions.
    Behrman A; Sulica L; He T
    Laryngoscope; 2004 Oct; 114(10):1693-700. PubMed ID: 15454756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voice disorders in the elderly.
    Gregory ND; Chandran S; Lurie D; Sataloff RT
    J Voice; 2012 Mar; 26(2):254-8. PubMed ID: 21530163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional voice outcomes after thyroidectomy: an assessment of the Dsyphonia Severity Index (DSI) after thyroidectomy.
    Henry LR; Helou LB; Solomon NP; Howard RS; Gurevich-Uvena J; Coppit G; Stojadinovic A
    Surgery; 2010 Jun; 147(6):861-70. PubMed ID: 20096434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective trial of voice outcomes after thyroidectomy: evaluation of patient-reported and clinician-determined voice assessments in identifying postthyroidectomy dysphonia.
    Stojadinovic A; Henry LR; Howard RS; Gurevich-Uvena J; Makashay MJ; Coppit GL; Shriver CD; Solomon NP
    Surgery; 2008 Jun; 143(6):732-42. PubMed ID: 18549889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of patient adherence to the recommendation for voice therapy.
    Portone C; Johns MM; Hapner ER
    J Voice; 2008 Mar; 22(2):192-6. PubMed ID: 17572065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of voice therapy in hyperfunctional dysphonia in adult patients.
    Kandoğan T; Koç M; Aksoy G
    Kulak Burun Bogaz Ihtis Derg; 2009; 19(4):198-202. PubMed ID: 19860634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Pediatric Voice Handicap Index with perceptual voice analysis in pediatric patients with vocal fold lesions.
    Johnson K; Brehm SB; Weinrich B; Meinzen-Derr J; de Alarcon A
    Arch Otolaryngol Head Neck Surg; 2011 Dec; 137(12):1258-62. PubMed ID: 22183908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between anxiety, type A personality, and treatment outcome of dysphonia due to benign causes.
    Ng JH; Lo S; Lim F; Goh S; Kanagalingam J
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):96-102. PubMed ID: 23112274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of clinician-based (GRBAS and CAPE-V) and patient-based (V-RQOL and IPVI) documentation of voice disorders.
    Karnell MP; Melton SD; Childes JM; Coleman TC; Dailey SA; Hoffman HT
    J Voice; 2007 Sep; 21(5):576-90. PubMed ID: 16822648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical versus laboratory ratings of voice using the CAPE-V.
    Solomon NP; Helou LB; Stojadinovic A
    J Voice; 2011 Jan; 25(1):e7-14. PubMed ID: 20430573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient factors related to voice therapy attendance and outcomes.
    Smith BE; Kempster GB; Sims HS
    J Voice; 2010 Nov; 24(6):694-701. PubMed ID: 20381305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.
    Morzaria S; Damrose EJ
    J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the Voice Handicap Index and voice measurements in four groups of patients with dysphonia.
    Schindler A; Mozzanica F; Vedrody M; Maruzzi P; Ottaviani F
    Otolaryngol Head Neck Surg; 2009 Dec; 141(6):762-9. PubMed ID: 19932851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.